We are live on ! Find out more
XTNT icon

Xtant Medical Holdings

25 hedge funds and large institutions have $5.1M invested in Xtant Medical Holdings in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

25% more funds holding

Funds holding: 2025 (+5)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

20% less capital invested

Capital invested by funds: $6.39M → $5.1M (-$1.29M)

Holders
25
Holders Change
+5
Holders Change %
+25%
% of All Funds
0.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
4
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change

XTNT Hedge Fund Activity: Q4 2013 in Review

25 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q4 2013, worth a combined $5.1M — down 20% from $6.39M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new XTNT positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was OrbiMed, adding an estimated $799K. The largest seller was Goldman Capital Management, cutting an estimated $495K.

  • 25 institutional investors held Xtant Medical Holdings (XTNT) as of Q4 2013, up from 20 in Q3 2013.
  • Funds reported $5.1M of Xtant Medical Holdings stock for Q4 2013, down 20% quarter-over-quarter.
  • 6 funds opened new Xtant Medical Holdings positions in Q4 2013 and 1 closed out, a net change of +5 holders.
  • The largest Xtant Medical Holdings buyer in Q4 2013 was OrbiMed, an estimated $799K added.
  • The largest Xtant Medical Holdings seller in Q4 2013 was Goldman Capital Management, an estimated $495K sold.

Based on aggregated 13F filings for Q4 2013.